Lisa Werr
Overview
Explore the profile of Lisa Werr including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
7
Citations
32
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Werr L, Bartenhagen C, Rosswog C, Cartolano M, Voegele C, Sexton-Oates A, et al.
J Clin Oncol
. 2024 Sep;
43(2):214-225.
PMID: 39348606
Purpose: The clinical course of pulmonary carcinoids ranges from indolent to fatal disease, suggesting that specific molecular alterations drive progression toward the fully malignant state. A similar spectrum of clinical...
2.
George J, Maas L, Abedpour N, Cartolano M, Kaiser L, Fischer R, et al.
Nature
. 2024 Mar;
627(8005):880-889.
PMID: 38480884
The evolutionary processes that underlie the marked sensitivity of small cell lung cancer (SCLC) to chemotherapy and rapid relapse are unknown. Here we determined tumour phylogenies at diagnosis and throughout...
3.
Werner J, Wollring M, Tscherpel C, Rosen E, Werr L, Stetter I, et al.
Neuro Oncol
. 2023 Mar;
25(6):1193-1195.
PMID: 36960770
No abstract available.
4.
Meeser A, Bartenhagen C, Werr L, Hellmann A, Kahlert Y, Hemstedt N, et al.
Cell Biosci
. 2022 Sep;
12(1):160.
PMID: 36153564
Background: Telomere maintenance mechanisms (TMM) are a hallmark of high-risk neuroblastoma, and are conferred by activation of telomerase or alternative lengthening of telomeres (ALT). However, detection of TMM is not...
5.
Fischer-Mertens J, Otte F, Roderwieser A, Rosswog C, Kahlert Y, Werr L, et al.
Cell Oncol (Dordr)
. 2022 Aug;
45(5):991-1003.
PMID: 35953764
Background: The majority of high-risk neuroblastomas harbor telomerase activity, and telomerase-interacting compounds, such as 6-thio-2'-deoxyguanosine (6-thio-dG), have been found to impair the growth of telomerase-positive neuroblastoma cell lines. It has...
6.
Lategahn J, Tumbrink H, Schultz-Fademrecht C, Heimsoeth A, Werr L, Niggenaber J, et al.
J Med Chem
. 2022 Apr;
65(9):6643-6655.
PMID: 35486541
Despite the clinical efficacy of epidermal growth factor receptor (EGFR) inhibitors, a subset of patients with non-small cell lung cancer displays insertion mutations in exon20 in EGFR and Her2 with...
7.
Werr L, Plenker D, Dammert M, Lorenz C, Bragelmann J, Tumbrink H, et al.
Mol Cancer Ther
. 2022 Mar;
21(5):821-830.
PMID: 35247925
NRG1 fusions are recurrent somatic genome alterations occurring across several tumor types, including invasive mucinous lung adenocarcinomas and pancreatic ductal adenocarcinomas and are potentially actionable genetic alterations in these cancers....